Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19
Jiwon Kim(Cornell University), Jonathan W. Weinsaft(Cornell University), Monika M. Safford, Parag Goyal(Cornell University), Sijun Kim(New York Hospital Queens), Hannah W. Mitlak(Cornell University), Romina Tafreshi(Cornell University), Leslee J. Shaw(American Institute for Economic Research), Alexander Volodarskiy(New York Hospital Queens), Evelyn M. Horn(Cornell University), Lakshmi Nambiar(Cornell University), Ingrid Hriljac(Cornell University), Arindam RoyChoudhury(Cornell University), Nupoor Narula(Cornell University), Meridith Pollie(Cornell University), Razia Sultana(Cornell University), Lishomwa C. Ndhlovu(Cornell University), Richard B. Devereux(Cornell University), Brian Yum(Cornell University)
Cited by 112
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|1.6k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k